Treatment with glucocorticoids can cause hyperglycemia, insulin resistance, and dyslipidemia; prolonged use has been shown to inhibit the secretion of FSH, TSH, and LH, leading to adrenal suppression and overall adrenal insufficiency when the treatment is stopped. Here, PLOD1 is linked to metabolic syndrome.